Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is NuVasive, Inc. (NUVA) A Good Stock To Buy?

With a general bullishness amongst the heavyweights, some big names were leading the bulls’ herd. Paul Marshall and Ian Wace’s Marshall Wace LLP initiated a $2.6 million position during the quarter. The other funds with brand new NuVasive, Inc. (NASDAQ:NUVA) positions are Chao Ku’s Nine Chapters Capital Management, Hal Mintz’s Sabby Capital, and Justin John Ferayorni’s Tamarack Capital Management.

Let’s go over hedge fund activity in other stocks – not necessarily in the same industry as NuVasive, Inc. (NASDAQ:NUVA) but similarly valued. We will take a look at HRG Group Inc (NYSE:HRG), Laclede Group Inc (NYSE:LG), Cantel Medical Corp. (NYSE:CMN), and Churchill Downs, Inc. (NASDAQ:CHDN). This group of stocks’ market values resembles NuVasive, Inc. (NASDAQ:NUVA)’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
HRG 26 1667547 0
LG 8 84602 -1
CMN 6 133874 0
CHDN 26 765391 4

As you can see, these stocks had an average of 17 hedge funds with bullish positions and the average amount invested in these stocks was $663 million. That figure was $622 million in NuVasive, Inc. (NASDAQ:NUVA)’s case. HRG Group Inc (NYSE:HRG) is the most popular stock in this table. On the other hand, Cantel Medical Corp. (NYSE:CMN) is the least popular one with only 6 bullish hedge fund positions. Compared to these stocks, NuVasive, Inc. (NASDAQ:NUVA) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.